EVLV_OUT_1 [2025-04-28 18:29:48 -0400] 6318 Bytes | 1617 tokens | Cum: 1617 tkns (20.21% of 8k)
==========================================================================

We are in the 'Lightning Round' baby! It's 6:29 PM on Mon Apr 28, 2025, and I'm firing up the spotlight on Evolv Technologies (EVLV), moving from $3.89 to $4.66. Is this a can’t-miss rocket or a one-hit wonder? Let’s dissect the numbers!

--- COMPANY PROFILE ---
Company: Evolv Technologies (EVLV)
IPO: 2021-07-19 (3 Years Ago)
Market Cap: $526,217,120
Shares Outstanding: 157,550,000
Industry: COMPUTER PERIPHERAL EQUIPMENT, NEC
Exchange: XNAS
Description: Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and advanced sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase and primarily under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

Here’s a list of headlines for Evolv Technologies:

Today 05:05PM - Evolv Technology Completes Restatement of Previously Issued Financial Statements and Reports Third Quarter, Fourth Quarter and Full Year 2024 Financial Results
Apr-23-25 08:00AM - Evolv Technology Appoints Chris Kutsor as Chief Financial Officer
Apr-22-25 05:00PM - Evolv Receives Expected Nasdaq Delinquency Notification
Apr-16-25 08:00AM - Partnership with Cosm Reinforces Evolv Technology's Sports Industry Position as Innovation Leader
Apr-10-25 08:00AM - San Francisco Giants Deploy Latest Evolv Express Gen2 Systems for 2025 Season
Mar-31-25 09:19AM - Evolv Technologies Holdings, Inc. (EVLV): A Bull Case Theory
Mar-31-25 09:19AM 08:00AM - Evolv Technology Announces that 92% of Customers1 Eligible to End Contracts Elect to Stay with Evolv
Mar-27-25 09:56AM - Is Evolv Technologies (EVLV) the Most Popular AI Penny Stock to Buy Under $5?
Mar-26-25 10:58AM - Is Evolv Technologies Holdings Inc. (NASDAQ:EVLV) the Best AI Stock to Invest in According to Reddit?
Mar-11-25 08:30AM - Evolv Technology Deployed Ballpark-Wide at T-Mobile Park for Seattle Mariners 2025 Opening Day
Feb-25-25 08:00AM - Evolv Announces Official Partnership with Sports Illustrated Stadium and New York Red Bulls
Feb-04-25 08:00AM - Evolv Technology Announces the Appointment of Richard Shapiro as a New Independent Director
Feb-03-25 08:00AM - Evolv Technology Announces Receipt of Extension from Nasdaq Stock Market
Jan-25-25 09:15AM - Evolv price target raised to $6.75 from $5.75 at Craig-Hallum
Jan-24-25 07:55PM - Why Is Larry Robbins Bullish on Evolv Technologies Holdings, Inc. (EVLV) Now?
Jan-24-25 07:55PM 08:30AM - Evolv Technology Announces Appointment of Chief Revenue Officer
Jan-23-25 08:00AM - Evolv Technology Provides Business Update
Jan-08-25 08:00AM - Built In Honors Evolv Technology in Its Esteemed 2025 Best Places To Work Awards
Dec-31-24 05:45AM - Levi & Korsinsky Notifies Evolv Technologies Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - EVLV
Dec-30-24 12:58PM - Evolv Technologies Holdings, Inc. Sued for Securities Law Violations Investors Should Contact Levi and Korsinsky Before December 31, 2024 to Discuss Your Rights EVLV
Dec-19-24 12:07PM - Evolv Technologies Holdings, Inc. Sued for Securities Law Violations - Contact Levi and Korsinsky Before December 31, 2024 to Discuss Your Rights EVLV
Dec-10-24 06:00AM - Shareholders of Evolv Technologies Holdings, Inc. Should Contact Levi and Korsinsky Before December 31, 2024 to Discuss Your Rights - EVLV

Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.

B1 - 2025-03-25T14:00:00Z - Video Surveillance-as-a-Service Market to Reach USD 17.8 Billion by 2032 | SNS Insider
B2 - 2024-12-30T17:58:00Z - Evolv Technologies Holdings, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before December 31, 2024 to Discuss Your Rights – EVLV
B3 - 2024-12-16T21:00:00Z - EVLV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Evolv Technologies Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
B4 - 2024-12-11T17:59:00Z - Evolv Technologies Holdings, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 31, 2024 to Discuss Your Rights – EVLV
B5 - 2024-12-11T11:00:00Z - INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) shareholders with losses to Contact the Firm
B6 - 2024-12-09T15:16:00Z - EVLV Investors Have Opportunity to Lead Evolv Technologies Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for Evolv Technologies (EVLV).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.

2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.

3) You will request information by referencing documents by their code.

4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.

5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.

Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.

NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`

EVLV_OUT_3 [2025-04-28 18:29:51 -0400] 984 Bytes | 267 tokens | Cum: 1886 tkns (23.57% of 8k)
==========================================================================

Showing B2 (chunk 1 of 1): B2:
**Evolv Technologies Holdings, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before December 31, 2024 to Discuss Your Rights – EVLV**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2024/12/30/3002816/3080/en/Evolv-Technologies-Holdings-Inc-Sued-for-Securities-Law-Violations-Investors-Should-Contact-Levi-Korsinsky-Before-December-31-2024-to-Discuss-Your-Rights-EVLV.htmlEvolv Technologies Holdings, Inc. (EVLV) is facing a class action lawsuit for alleged securities fraud between August 2022 and October 2024, with claims of improper revenue recognition and misconduct concerning sales to a major channel partner.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

EVLV_OUT_5 [2025-04-28 18:29:52 -0400] 929 Bytes | 258 tokens | Cum: 2146 tkns (26.82% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-28T21:24:23Z - Evolv Technology Completes Restatement of Previously Issued Financial Statements and Reports Third Q...
A2 - 2025-04-28T21:06:08Z - Evolv Technology Completes Restatement of Previously Issued Financial Statements and Reports Third Q...
A3 - 2025-04-23T12:24:00Z - Evolv Technologies Appoints Chris Kutsor As Chief Financial Officer...
A4 - 2025-04-23T12:00:00Z - Evolv Technology Appoints Chris Kutsor as Chief Financial Officer...
A5 - 2025-04-23T12:16:11Z - Evolv Technologies names Chris Kutsor as CFO (EVLV:NASDAQ)...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

EVLV_OUT_7 [2025-04-28 18:29:52 -0400] 1182 Bytes | 281 tokens | Cum: 2429 tkns (30.36% of 8k)
==========================================================================

Showing A1 (chunk 1 of 22): A1:
**Evolv Technology Completes Restatement of Previously Issued Financial Statements and Reports Third Quarter, Fourth Quarter and Full Year 2024 Financial Results**Date: 2025-04-28Source: {'uri': 'wallstreet-online.de', 'dataType': 'news', 'title': 'wallstreet:online'}URL: https://www.wallstreet-online.de/nachricht/19279090-evolv-technology-completes-restatement-of-previously-issued-financial-statements-and-reports-third-quarter-fourth-quarter-and-full-year-2024-financial-results"Completing this restatement -- which brings the Company back into full compliance with SEC reporting and Nasdaq listing requirements -- marks an important milestone in our ongoing work to rebuild stakeholder confidence," said John Kedzierski, President and Chief Executive Officer of Evolv Technology, Inc. "Looking ahead, we are focused on prioritizing disciplined execution, transparent communication, and an u

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

EVLV_OUT_9 [2025-04-28 18:29:53 -0400] 1182 Bytes | 300 tokens | Cum: 2731 tkns (34.14% of 8k)
==========================================================================

Showing A1 (chunk 2 of 22): nwavering commitment to best-in-class compliance. With both the restatement and the FTC resolution now firmly behind us and having achieved our long-standing profitability goals six months ahead of schedule, we believe we are well-positioned as we enter our next phase of growth. We are poised to lead the transformation of the security technology landscape -- making the world a safer place where people can live, work, learn, and play."

Total revenue for the third quarter of 2024 was $27.4 million, an increase of 37% compared to $20.0 million (as restated) for the third quarter of 2023. Annual Recurring Revenue ("ARR") was $93.7 million at the end of third quarter of 2024, an increase of 46% compared to $64.4 million (as restated) at the end of the third quarter of 2023. Net loss for the third quarter of 2024 was $(30.4) million, or $(0.19) per basic and diluted share, compared to net inc

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

EVLV_OUT_11 [2025-04-28 18:29:54 -0400] 1182 Bytes | 349 tokens | Cum: 3082 tkns (38.52% of 8k)
==========================================================================

Showing A1 (chunk 3 of 22): ome of $5.0 million (as restated), or $0.03 (as restated) per basic and diluted share, in the third quarter of 2023. Adjusted earnings (loss) for the third quarter of 2024 was $(6.9) million, or $(0.04) per diluted share, compared to adjusted earnings (loss) of $(12.4) million (as restated), or $(0.08) per diluted share, for the third quarter of 2023. Adjusted EBITDA for the third quarter of 2024 was $(3.0) million compared to $(11.6) million (as restated) in the third quarter of 2023. As of September 30, 2024, the Company had cash, cash equivalents, marketable securities, and restricted cash of $56.3 million and no debt.

Total revenue for the nine months ended September 30, 2024 was $74.8 million, an increase of 27% compared to $59.0 million (as restated) for the nine months ended September 30, 2023. Net loss for the nine months ended September 30, 2024 was $(38.3) million, or $(0.25)

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

EVLV_OUT_13 [2025-04-28 18:29:55 -0400] 1182 Bytes | 340 tokens | Cum: 3424 tkns (42.80% of 8k)
==========================================================================

Showing A1 (chunk 4 of 22): per basic and diluted share, compared to $(90.9) million (as restated), or $(0.61) (as restated) per basic and diluted share, in the nine months ended September 30, 2023. Adjusted earnings (loss) for the nine months ended September 30, 2024 was $(30.8) million, or $(0.20) per diluted share, compared to adjusted earnings (loss) of $(44.2) million (as restated), or $(0.30) (as restated) per diluted share, for the nine months ended September 30, 2023. Adjusted EBITDA for the nine months ended September 30, 2024 was $(21.3) million compared to $(41.6) million (as restated) in the nine months ended September 30, 2023.

Results for the Fourth Quarter of 2024

Total revenue for the fourth quarter of 2024 was $29.1 million, an increase of 41% compared to $20.6 million (as restated) for the fourth quarter of 2023. Annual Recurring Revenue ("ARR") was $99.4 million at the end of fourth quarter of

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

EVLV_OUT_15 [2025-04-28 18:29:56 -0400] 1182 Bytes | 342 tokens | Cum: 3768 tkns (47.10% of 8k)
==========================================================================

Showing A1 (chunk 5 of 22): 2024, an increase of 39% compared to $71.3 million (as restated) at the end of the fourth quarter of 2023. Net loss for the fourth quarter of 2024 was $(15.7) million, or $(0.10) per basic and diluted share, compared to net loss of $(17.2) million (as restated), or $(0.11) per basic and diluted share, in the fourth quarter of 2023. Adjusted earnings (loss) for the fourth quarter of 2024 was $(4.4) million, or $(0.03) per diluted share, compared to adjusted earnings (loss) of $(11.8) million (as restated), or $(0.08) (as restated) per diluted share, for the fourth quarter of 2023. Adjusted EBITDA for the fourth quarter of 2024 was $0.4 million compared to $(10.3) million (as restated) in the fourth quarter of 2023. As of December 31, 2024, the Company had cash, cash equivalents, marketable securities, and restricted cash of $51.9 million and no debt. Remaining Performance Obligation as of

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

EVLV_OUT_17 [2025-04-28 18:29:56 -0400] 1182 Bytes | 324 tokens | Cum: 4094 tkns (51.18% of 8k)
==========================================================================

Showing A1 (chunk 6 of 22): December 31, 2024 was $266.7 million. The Company had approximately 6,100 units deployed as of December 31, 2024, reflecting a one time adjustment to remove approximately (100) non-revenue generating units from the Company's deployed unit count related to Evolv Edge, the Company's first generation product offering.

Total revenue for the twelve months ended December 31, 2024 was $103.9 million, an increase of 31% compared to $79.6 million (as restated) for the twelve months ended December 31, 2023. Net loss for the twelve months ended December 31, 2024 was $(54.0) million, or $(0.34) per basic and diluted share, compared to $(108.0) million (as restated), or $(0.72) (as restated) per basic and diluted share, in the twelve months ended December 31, 2023. Adjusted earnings (loss) for the twelve months ended December 31, 2024 was $(35.3) million, or $(0.23) per diluted share, compared to a

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

EVLV_OUT_19 [2025-04-28 18:29:57 -0400] 1182 Bytes | 286 tokens | Cum: 4382 tkns (54.77% of 8k)
==========================================================================

Showing A1 (chunk 7 of 22): djusted earnings (loss) of $(56.0) million (as restated), or $(0.38) (as restated) per diluted share, for the twelve months ended December 31, 2023. Adjusted EBITDA for the twelve months ended December 31, 2024 was $(21.0) million compared to $(51.8) million (as restated) in the twelve months ended December 31, 2023.

The following table summarizes the breakdown of recurring and non-recurring revenue for each period presented:

The following table summarizes operating cash flows for each period presented:

About Evolv Technology

Evolv Technologies Holdings, Inc (NASDAQ: EVLV) is designed to transform human security to make a safer, faster, and better experience for the world's most iconic venues and companies as well as schools, hospitals, and public spaces, using industry leading artificial intelligence (AI)-powered screening and analytics. Its mission is to transform security to creat

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

EVLV_OUT_21 [2025-04-28 18:29:57 -0400] 1182 Bytes | 284 tokens | Cum: 4668 tkns (58.35% of 8k)
==========================================================================

Showing A1 (chunk 8 of 22): e a safer world to live, work, learn, and play. Evolv has digitally transformed the gateways in many places where people gather by enabling seamless integration combined with powerful analytics and insights. Evolv's advanced systems have scanned more than two billion people since 2019. Evolv has been awarded the U.S. Department of Homeland Security (DHS) SAFETY Act Designation as a Qualified Anti-Terrorism Technology (QATT) as well as the Security Industry Association (SIA) 2024 New Products and Solutions (NPS) Award in the Law Enforcement/Public Safety/Guarding Systems category, as well as Sport Business Journal's (SBJ) 2024 awards for "Best In Fan Experience Technology" and "Best In Sports Technology". Evolv, Evolv Express, Evolv Insights, Evolv Visual Gun Detection, Evolv eXpedite, and Evolv Eva are registered trademarks or trademarks of Evolv Technologies, Inc. in the United States a

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

EVLV_OUT_23 [2025-04-28 18:29:58 -0400] 1182 Bytes | 243 tokens | Cum: 4913 tkns (61.41% of 8k)
==========================================================================

Showing A1 (chunk 9 of 22): nd other jurisdictions. For more information, visit evolv.com.

Non-GAAP Financial Measures In this press release, the Company's adjusted gross profit (loss), adjusted gross margin, adjusted operating expenses, adjusted operating income (loss), adjusted EBITDA, adjusted earnings (loss), and adjusted earnings per diluted share are not presented in accordance with generally accepted accounting principles (GAAP) and are not intended to be used in lieu of GAAP presentations of results of operations. Adjusted operating expenses is defined as operating expenses less stock-based compensation expense, loss on impairment of lease equipment, one-time employee separation costs, and one-time legal and regulatory costs, which management believes provides a more meaningful representation of on-going operating expense levels. One time legal and regulatory costs include one-time legal, accounting and pr

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

EVLV_OUT_25 [2025-04-28 18:30:00 -0400] 1083 Bytes | 264 tokens | Cum: 5179 tkns (64.74% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-04-28 10-K ITEM 7. MGT DISC & ANALYSIS OF FIN COND & RESULTS OF OPER

You should read the following discussion and analysis of our financial condition and results of operations together with our audited CONS financial statements and related notes...

S2 - 2025-04-28 10-Q an style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have restated our previously issued condensed CONS financial statements contained in this Quarterly Report on Form 10-Q. Refer to the Explanatory Note pre...

S3 - 2025-04-28 8-K Item 2.02 Results of Oper and Fin Cond.

On April 28, 2025, Evolv Technologies Holdings, Inc. (the Company), in connection with its restatement of certain historical financial statements, filed with the Securities and Exchange Commission its Quarterly Report on ...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

EVLV_OUT_27 [2025-04-28 18:30:01 -0400] 1181 Bytes | 252 tokens | Cum: 5433 tkns (67.91% of 8k)
==========================================================================

Showing S1 (chunk 1 of 6): S1:
ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion and analysis of our financial condition and results of operations together with our audited consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K. This discussion contains forward-looking statements based upon current plans, expectations and beliefs involving risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under Risk Factors and in other parts of this Annual Report on Form 10- K.

As used in this Annual Report on Form 10-K, unless otherwise indicated or the context otherwise requires, references to we, us, our, the Company and Evolv refer to the consolidated operati

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

EVLV_OUT_29 [2025-04-28 18:30:02 -0400] 1181 Bytes | 273 tokens | Cum: 5708 tkns (71.35% of 8k)
==========================================================================

Showing S1 (chunk 2 of 6): ons of Evolv Technologies Holdings, Inc. and its subsidiaries. References to NHIC refer to our legal predecessor, a special purpose acquisition company, prior to the consummation of our business combination on July 16, 2021 (the Merger) and references to Legacy Evolv refer to Evolv Technologies, Inc. dba Evolv Technology, Inc. prior to the consummation of the Merger.

Restatement of Prior Period Financial Statements

We have restated our previously issued consolidated financial statements contained in this Annual Report on Form 10-K. Refer to the Explanatory Note preceding Item 1, Business, for background on the restatement, the periods impacted, control considerations, and other information. In addition, we have restated certain previously reported financial information for the fiscal years ended December 31, 2023 and December 31, 2022 and for the quarterly periods and year-to-date pe

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

EVLV_OUT_31 [2025-04-28 18:30:02 -0400] 1181 Bytes | 281 tokens | Cum: 5991 tkns (74.89% of 8k)
==========================================================================

Showing S1 (chunk 3 of 6): riods ended June 30, 2022, September 30, 2022, March 31, 2023, June 30, 2023, September 30, 2023, March 31, 2024, and June 30, 2024 in this Item 7, Managements Discussion and Analysis of Financial Condition and Results of Operations, including but not limited to information within the Results of Operations section. See Notes 2 and 23 in the notes to the consolidated financial statements in this Annual Report on Form 10-K, for additional information related to the restatement, including descriptions of the misstatements and the impacts on our consolidated financial statements.

Business Overview

Evolv is a leading security technology company pioneering Artificial Intelligence (AI)-powered screening designed to help create safer experiences, with key market categories that include education, healthcare, sports, and live entertainment. Our mission is to make the world a safer and more en

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

EVLV_OUT_33 [2025-04-28 18:30:03 -0400] 1181 Bytes | 251 tokens | Cum: 6244 tkns (78.05% of 8k)
==========================================================================

Showing S1 (chunk 4 of 6): joyable place to live, work, learn, and play. Our goal is to help facility operators address the chronic epidemic of escalating gun violence, mass shootings and terrorist attacks while maintaining a positive visitor experience.

Our solutions combine proprietary software and hardware, delivered as a long-term Security-as-a-Service ("SaaS") subscription model and are designed to enhance security and improve the visitor experience. Evolv provides a cloud-connected, AI-driven approach to security that goes beyond just hardware, supporting the end-to-end screening experience. Our focus is weapons detection, and we offer two core solutions: Evolv Express and Evolv eXpedite designed to efficiently screen high volumes of people and bags for concealed threats.

Our flagship product, Evolv Express, uses advanced sensors, AI-powered software, and cloud services to not only consistently detect fi

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

EVLV_OUT_35 [2025-04-28 18:30:04 -0400] 1181 Bytes | 238 tokens | Cum: 6484 tkns (81.05% of 8k)
==========================================================================

Showing S1 (chunk 5 of 6): rearms, improvised explosives, and certain types of knives and distinguish them from many harmless items such as cell phones and keys, but also visualize the location of the potential threat helping to enable security personnel to conduct targeted, minimally intrusive secondary screenings. Evolv eXpedite, our autonomous X-ray bag scanning solution, works with Evolv Express to provide a layered approach to security for concealed weapons detection in high clutter environments. Using eXpedite with Express aims to allow the checkpoint to operate at heightened sensitivity while potentially reducing the burden on security staff and optimizing the visitor experience.

Our innovative technology is designed to enhance security and provide an efficient, positive visitor and customer experience. In addition to screening capabilities, our solution includes Evolv Insights, a powerful software analyt

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

EVLV_OUT_37 [2025-04-28 18:30:04 -0400] 790 Bytes | 168 tokens | Cum: 6654 tkns (83.17% of 8k)
==========================================================================

Showing S1 (chunk 6 of 6): ics dashboard that allows customers to comprehensively review, analyze, and gather insights from the Evolv Express screening systems at their various venue or facility locations. Available data includes visitor arrival patterns, throughput volumes, system detection performance, alarm statistics, and detection settings. Our customers can leverage this data to inform their security operations, while providing end-users with an approachable security experience. Our products, which are offered to our cu...

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

EVLV_OUT_39 [2025-04-28 18:30:11 -0400] 7478 Bytes | 2070 tokens | Cum: 8726 tkns (109.08% of 8k)
==========================================================================

This is our set of metrics for Evolv Technologies.
Please analyze the numbers.

+-------------------+-----------------------+-------------------------+-----------------------+
| Volume: 1,777,304 | Perf Month: 30.82% | Option/Short: Yes / Yes | Sales Y/Y TTM: 17.67% |
+-------------------+-----------------------+-------------------------+-----------------------+
| Avg Volume: 1.28M | Perf Quarter: 3.74% | Short Float: 14.68% | ROE: -12.83% |
+-------------------+-----------------------+-------------------------+-----------------------+
| Rel Volume: 1.39 | Index: RUT | Short Ratio: 12.43 | ROI: -12.41% |
+-------------------+-----------------------+-------------------------+-----------------------+
| RSI (14): 73.28 | Market Cap: 655.41M | Short Interest: 15.90M | Sales Surprise: 0.00% |
+-------------------+-----------------------+-------------------------+-----------------------+
| ATR (14): 0.24 | Shs Outstand: 157.47M | Beta: 1.62 | EPS Surprise: 0.00% |
+-------------------+-----------------------+-------------------------+-----------------------+
| SMA20: 26.85% | Shs Float: 108.31M | Sales Q/Q: 28.83% | P/E: - |
+-------------------+-----------------------+-------------------------+-----------------------+
| SMA50: 25.97% | Inst Own: 42.81% | Sales past 5Y: - | Earnings: Feb 27 |
+-------------------+-----------------------+-------------------------+-----------------------+
| SMA200: 18.24% | Insider Own: 31.25% | Employees: - | |
+-------------------+-----------------------+-------------------------+-----------------------+
| Perf Week: 30.41% | Insider Trans: -0.42% | Debt/Eq: 0.02 | |
+-------------------+-----------------------+-------------------------+-----------------------+

The next section covers any insider trading by Evolv Technologies officers or majority shareholders (if available).

Inside Trans: Evolv Technologies Holdings, Inc. (EVLV) by Sullivan Mark J. (Unknown Title) on 2025-03-03
- Restricted Stock Units: 7575 shares at $0 (D)

Inside Trans: Evolv Technologies Holdings, Inc. (EVLV) by Chitkara Anil (Founder & Chief Growth Officer) on 2025-03-01
- Class A Common Stock: 47765 shares at $0 (D)
- Class A Common Stock: 53413 shares at $0 (D)
- Class A Common Stock: 45913 shares at $0 (D)
- Class A Common Stock: 72148 shares at $3.3 (D)
- Restricted Stock Units: 47765 shares at $0 (D)
- Restricted Stock Units: 53413 shares at $0 (D)
- Restricted Stock Units: 45913 shares at $0 (D)
- Restricted Stock Units: 113636 shares at $0 (D)
- Restricted Stock Units: 85227 shares at $0 (D)

Inside Trans: Evolv Technologies Holdings, Inc. (EVLV) by Ellenbogen Michael (Founder & Chief Innovation Ofc) on 2025-03-01
- Class A Common Stock: 47765 shares at $0 (D)
- Class A Common Stock: 66767 shares at $0 (D)
- Class A Common Stock: 57392 shares at $0 (D)
- Class A Common Stock: 56263 shares at $3.3 (D)
- Restricted Stock Units: 47765 shares at $0 (D)
- Restricted Stock Units: 66767 shares at $0 (D)
- Restricted Stock Units: 57392 shares at $0 (D)
- Restricted Stock Units: 151515 shares at $0 (D)
- Restricted Stock Units: 113636 shares at $0 (D)

Inside Trans: Evolv Technologies Holdings, Inc. (EVLV) by Marshall Robert E (Chief Revenue Officer) on 2025-03-03
- Restricted Stock Units: 409090 shares at $0 (D)
- Restricted Stock Units: 306818 shares at $0 (D)

No transactions recorded.

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 25540000.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': 3462000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 4.16
Average Volume: 1669877.9
30-Day High: 4.16
30-Day Low: 2.85

[Detailed Financials: Q2 2024]
- Total Assets: $268,517,000.00
- Total Liabilities: $115,444,000.00
- Total Equity: $153,073,000.00
- Current Assets: $137,899,000.00
- Current Liabilities: $79,409,000.00

[Income Statement: Q2 2024]
- Revenue: $25,540,000.00
- Net Income: $3,462,000.00
- Gross Profit: $14,472,000.00
- Operating Income: $-22,327,000.00
- Earnings Per Share (EPS): 0.02

[Cash Flow Statement: Q2 2024]
- Net Cash Flow: $-8,898,000.00

[Detailed Financials: Q1 2024]
- Total Assets: $282,260,000.00
- Total Liabilities: $140,671,000.00
- Total Equity: $141,589,000.00
- Current Assets: $141,802,000.00
- Current Liabilities: $79,922,000.00

[Income Statement: Q1 2024]
- Revenue: $21,668,000.00
- Net Income: $-11,644,000.00
- Gross Profit: $11,772,000.00
- Operating Income: $-22,278,000.00
- Earnings Per Share (EPS): -0.08

[Cash Flow Statement: Q1 2024]
- Net Cash Flow: $-22,566,000.00
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of Evolv Technologies (EVLV).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about Evolv Technologies.

2) MARKET_SCORE[]
This conversation was initiated because EVLV is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for EVLV.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, EVLV could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect EVLV to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of Evolv Technologies.

11) ETHICAL_RATING[]
Rate Evolv Technologies’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of Evolv Technologies.
Provide any reasons you can use to support it.

Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

EVLV_IN_41 [2025-04-28 18:30:11 -0400] 126 Bytes | 29 tokens | Cum: 8947 tkns (111.84% of 8k)
==========================================================================

====================================
[2025-04-28 18:30:11] # Analysis Completed
Elapsed Time: 24.16 seconds